1
Clinical Trials associated with Birch cluster immunotherapy(Inmunotek SL) / Not yet recruitingNot Applicable Efficacy and safety of subcutaneous cluster immunotherapy with cluster-allergoid CLUSTOID® (glutaraldehyde-polymerized allergen extract of mixtures of grass and rye allergens – Holcus lanatus, Dactylis glomerata, Lolium perenne, Phleum pratense, Poa pratensis, Festuca elatior, Secale cereale) in patients with allergic rhinoconjunctivitis sensitized to grass and with or without rye pollen sensitization. A prospective, double-blind, randomized, placebo-controlled, multi-centre trial. - Specific Immunotherapy with CLUSTOID®: Efficacy and safety
100 Clinical Results associated with Birch cluster immunotherapy(Inmunotek SL)
100 Translational Medicine associated with Birch cluster immunotherapy(Inmunotek SL)
100 Patents (Medical) associated with Birch cluster immunotherapy(Inmunotek SL)
100 Deals associated with Birch cluster immunotherapy(Inmunotek SL)